Treatment with the ALK inhibitor of mice injected with sorted by
relevance

Admin13.07.2021

Treatment with the ALK inhibitor of mice injected with

6306
Admin12.08.2021

Treatment with the ALK inhibitor of mice injected with

8702
Admin04.08.2021

ALK is detected in melanoma samples. (a

606
Admin25.09.2021

The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes

303
Admin22.09.2021

Discovery and Characterization of Recurrent, Targetable

1009
Admin12.09.2021

LRRC4 combined with TMZ treatment prolonged mouse survival

8508
Admin30.07.2021

ALK RNA and protein levels increase after gefitinib

1505
Admin27.08.2021

Pharmacologic inhibition of PI3K p110δ in mutant Shp2E76K

3800
Admin30.08.2021

Effects of CI-994 histone deacetylase inhibitor treatment

1905
Admin20.07.2021

The ALK Inhibitor Ceritinib Overcomes Crizotinib

1201
Admin26.07.2021

ALK inhibitor-resistant cells exhibit stable resistance in

5103
Admin19.08.2021

Mice were injected with 10⁶ tumor cells in the left

7602
Admin05.10.2021

Cbl inhibitor treatment attenuates acute ulcerative

4800
Admin26.07.2021

Combined treatment with ENTPD2 inhibitor and anti-PD-1

5302
Admin04.08.2021

DMOG treatment does not protect p50 -/-mice from LPS

7010
Admin30.07.2021

Treatment of mice with the SPPL2a inhibitor 40 leads to a

7300
Admin06.08.2021

Pharmacological treatment with XPO1 inhibitors reduces

9101
Admin27.07.2021

Reduced PAK1 activity sensitizes FA/BRCA-proficient breast

904
Admin17.08.2021

XPO-1 inhibitor SXR resensitizes BT474 xenograft tumors to

9008
Admin04.10.2021

FAK inhibitor protects lung fibrosis in bleomycin

1407
Admin22.09.2021

Proteasome inhibition after continuous treatment in vitro

9104